News tagged with medical oncology
Related topics: patients , breast cancer , cancer , lung cancer , cancer cells
Phase III data in treatment of renal cell carcinoma reported
New results from phase III trials exploring treatment options for patients with advanced renal cell carcinoma were released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
Cancer
Oct 01, 2012 |
not rated yet |
0
First large scale trial of whole-genome cancer testing for clinical decision-making reported
For the first time, researchers have conducted a large trial in which they tested the entire genome of individual breast cancers to help personalize treatment. They released their findings at the ESMO 2012 Congress of the ...
Cancer
Oct 01, 2012 |
not rated yet |
0
New findings highlight the challenges of managing blood clotting in cancer patients
New findings that highlight the challenges of managing thromboembolic events in patients being treated for cancer were released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
Cancer
Oct 01, 2012 |
not rated yet |
0
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer
The results of a new phase III trial show that crizotinib, a targeted therapy, is a more effective treatment than standard chemotherapy for patients with advanced, ALK-positive lung cancer, researchers said at the ESMO 2012 ...
Cancer
Sep 30, 2012 |
not rated yet |
0
Myths and misunderstandings hamper efforts to prevent cancer
New insights on the global fight to prevent cancers were presented during the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. The studies highlight the challenges of overcoming misunderstandings ...
Cancer
Sep 30, 2012 |
2 / 5 (2) |
0
Studies show drug combinations effective for melanoma
Promising new data on drug combinations to treat metastatic melanoma are presented at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
Cancer
Sep 29, 2012 |
not rated yet |
0
Governments failing to address 'global pandemic of untreated cancer pain'
Governments around the world are leaving hundreds of millions of cancer patients to suffer needlessly because of their failure to ensure adequate access to pain-relieving drugs, an unprecedented new international survey reveals.
Cancer
Sep 29, 2012 |
5 / 5 (2) |
3
Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer
Treatment with the drug sorafenib as a third or fourth line therapy does not result in improved overall survival among patients with advanced non-small cell lung cancer (NSCLC), according to findings released at the ESMO ...
Cancer
Sep 29, 2012 |
not rated yet |
0
Studies show advances in gastrointestinal cancer treatments
New trial data showing improvements in the treatment of esophageal and gastrointestinal cancers were released today at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
Cancer
Sep 29, 2012 |
not rated yet |
0
The true costs of cancer in Europe revealed
New studies that reveal for the first time the real economic and human costs of caring for cancer patients in Europe will be presented during the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
Cancer
Sep 28, 2012 |
not rated yet |
0
Urgent need for integrated oncology and palliative care
The European Society for Medical Oncology (ESMO) has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centers. The centers will receive the acknowledgment at the ESMO ...
Cancer
Sep 24, 2012 |
not rated yet |
0
It's time cinema directors realized cancer isn't always a death sentence, study says
Films that feature characters with cancer have become a familiar sight for movie-goers in recent years, but they rarely portray the patient's chances of survival accurately, Italian reserachers will report at the ESMO 2012 ...
Cancer
Sep 19, 2012 |
not rated yet |
0
Researchers reveal underlying mechanism of powerful chemotherapy for prostate cancer treatment
The power of taxane-based chemotherapy drugs are misunderstood and potentially underestimated, according to researchers at Weill Cornell Medical College in the September 15 issue of the journal Cancer Research.
Cancer
Sep 17, 2012 |
not rated yet |
0
Researchers study childhood melanoma characteristics
Melanoma, newly diagnosed in more than 76,000 Americans in 2011, is the most common and dangerous form of skin cancer. Melanoma is rare in children, accounting for 1 to 4 percent of all melanoma cases and just 3 percent of ...
Cancer
Sep 07, 2012 |
not rated yet |
0
Novel therapeutic targets identified for small cell lung cancer
Newly discovered molecular differences between small cell lung cancer and nonsmall cell lung cancer have revealed PARP1 and EZH2 as potential therapeutic targets for patients with small cell lung cancer, according to the ...
Cancer
Sep 06, 2012 |
not rated yet |
0
|
